ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
21.75
-0.58 (-2.60%)
Apr 25, 2025, 12:45 PM EDT - Market open
ADMA Biologics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 103.15 | 51.35 | 86.52 | 51.09 | 55.92 | Upgrade
|
| Cash & Short-Term Investments | 103.15 | 51.35 | 86.52 | 51.09 | 55.92 | Upgrade
|
| Cash Growth | 100.86% | -40.65% | 69.36% | -8.64% | 109.03% | Upgrade
|
| Receivables | 50 | 27.42 | 15.51 | 28.58 | 13.24 | Upgrade
|
| Inventory | 170.24 | 172.91 | 163.28 | 124.72 | 81.54 | Upgrade
|
| Prepaid Expenses | 8.03 | 5.33 | 5.1 | 4.34 | 3.05 | Upgrade
|
| Total Current Assets | 331.41 | 257.01 | 270.4 | 208.73 | 153.74 | Upgrade
|
| Property, Plant & Equipment | 63.34 | 63.47 | 68.75 | 58.2 | 45.85 | Upgrade
|
| Goodwill | 3.53 | 3.53 | 3.53 | 3.53 | 3.53 | Upgrade
|
| Other Intangible Assets | 0.46 | 0.5 | 1.01 | 1.73 | 2.44 | Upgrade
|
| Long-Term Deferred Tax Assets | 84.28 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | 5.66 | 4.67 | 4.77 | 4.07 | 2.11 | Upgrade
|
| Total Assets | 488.68 | 329.18 | 348.46 | 276.25 | 207.67 | Upgrade
|
| Accounts Payable | 20.22 | 15.66 | 13.23 | 12.43 | 11.07 | Upgrade
|
| Accrued Expenses | 28.63 | 30.55 | 23.19 | 16.23 | 8.16 | Upgrade
|
| Current Portion of Leases | 1.22 | 1.05 | 0.91 | 0.59 | 0.37 | Upgrade
|
| Current Income Taxes Payable | 3.48 | - | - | - | - | Upgrade
|
| Current Unearned Revenue | 0.14 | 0.18 | 0.14 | 0.14 | 0.14 | Upgrade
|
| Other Current Liabilities | 1.85 | 2.37 | 1.8 | 0.98 | 0.21 | Upgrade
|
| Total Current Liabilities | 55.54 | 49.81 | 39.27 | 30.38 | 19.95 | Upgrade
|
| Long-Term Debt | 72.34 | 130.59 | 142.83 | 94.87 | 92.97 | Upgrade
|
| Long-Term Leases | 8.56 | 9.78 | 10.7 | 7.46 | 4.33 | Upgrade
|
| Long-Term Unearned Revenue | 1.55 | 1.69 | 1.83 | 1.98 | 2.12 | Upgrade
|
| Other Long-Term Liabilities | 1.67 | 2.11 | 1.85 | 0.4 | 0.05 | Upgrade
|
| Total Liabilities | 139.66 | 193.98 | 196.49 | 135.08 | 119.42 | Upgrade
|
| Common Stock | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 657.58 | 641.44 | 629.97 | 553.27 | 428.7 | Upgrade
|
| Retained Earnings | -308.58 | -506.26 | -478.02 | -412.11 | -340.47 | Upgrade
|
| Shareholders' Equity | 349.02 | 135.21 | 151.97 | 141.17 | 88.25 | Upgrade
|
| Total Liabilities & Equity | 488.68 | 329.18 | 348.46 | 276.25 | 207.67 | Upgrade
|
| Total Debt | 82.12 | 141.42 | 154.44 | 102.92 | 97.67 | Upgrade
|
| Net Cash (Debt) | 21.03 | -90.07 | -67.92 | -51.83 | -41.75 | Upgrade
|
| Net Cash Per Share | 0.09 | -0.40 | -0.34 | -0.37 | -0.48 | Upgrade
|
| Filing Date Shares Outstanding | 237.62 | 228.22 | 222.16 | 195.92 | 121.28 | Upgrade
|
| Total Common Shares Outstanding | 236.62 | 226.06 | 221.82 | 195.81 | 104.9 | Upgrade
|
| Working Capital | 275.87 | 207.21 | 231.14 | 178.35 | 133.79 | Upgrade
|
| Book Value Per Share | 1.48 | 0.60 | 0.69 | 0.72 | 0.84 | Upgrade
|
| Tangible Book Value | 345.03 | 131.18 | 147.43 | 135.91 | 82.28 | Upgrade
|
| Tangible Book Value Per Share | 1.46 | 0.58 | 0.66 | 0.69 | 0.78 | Upgrade
|
| Land | 4.34 | 4.34 | 4.34 | 4.34 | 4.34 | Upgrade
|
| Buildings | 21.79 | 20.22 | 19.54 | 19.07 | 17.4 | Upgrade
|
| Machinery | 32.92 | 32.93 | 29.2 | 24.17 | 20.11 | Upgrade
|
| Construction In Progress | 8.15 | 2.27 | 6.73 | 5.5 | 3.34 | Upgrade
|
| Leasehold Improvements | 21.07 | 20.81 | 17.93 | 11.13 | 5.27 | Upgrade
|
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.